Abstract
An integrated approach to agent detection and identification provides the most reliable laboratory data and is essential to a complete and accurate disease diagnosis. To achieve more rapid biological agent identification with a high level of confidence, a combination of state-of-the-art antigen and nucleic acid analysis methods is required. The most significant problem associated with the development of an integrated diagnostic system has been the inability of antigen-detection technologies to detect agents with sensitivities approaching those of nucleic acid-detection technologies. These differences in assay sensitivity increase the probability of obtaining disparate results, thus complicating medical decisions. However, advances in immunodiagnostic technologies provide the basis for developing antigen-detection platforms capable of meeting stringent requirements for sensitivity, specificity, assay speed, robustness, and simplicity. Such advances must be exploited to increase the confidence of immunodiagnostic testing and to ensure the success of the integrated approach toward diagnosis of disease caused by biological warfare (BW) agents.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Malmqvist, M. (1993) Surface plasmon resonance for detection and measurement of antibody-antigen affinity and kinetics. Curr. Opin. Immunol. 5, 282–286.
Wabl, M., Cascalho, M., and Steinberg, C. (1999) Hypermutation in antibody affinity maturation. Curr. Opin. Immunol. 11, 186–189.
Neuberger, M. S., Ehrenstein, M. R., Rada, C., et al. (2000) Memory in the B-cell compartment: antibody affinity maturation. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 355, 357–360.
Rudin, C. M. and Thompson, C. B. (1998) B-cell development and maturation. Semin. Oncol. 25, 435–446.
Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256, 495–497.
Allison, L. M. C., Salter, M. W. A. P., Kiguwa, S., and Howard, C. R. (1991) Analysis of the glycoprotein gene of Tacaribe virus and neutralization-resistant variants. J. Gen. Virol. 72, 2025–2029.
Agapov, Y. V., Lebedeva, S. D., Razumov, I. A., et al. (1992) Models of Venezuelan equine encephalomyelitis virus resistant to neutralization effect of monoclonal antibodies. Doklady Akademii Nauk SSSR 320, 24–26.
Ketterlinus, R., Wiegers, K., and Dernick, R. (1993) Revertants of poliovirus escape mutants: new insights into antigenic structures. Virology 192, 525–533.
Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1317.
Huse, W. D., Sastry, L., Iverson, S. A., et al. (1989) Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246, 1275–1281.
Persson, M. A., Caothien, R. H., and Burton, D. R. (1991) Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. USA 88, 2432–2436.
Burton, D. R., Barbas, C. F., III, Persson, M. A., Koenig, S., Chanock, R. M., and Lerner, R. A. (1991) A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88, 10,134–10,137.
Nakayama, G. R., Valkirs, G., McGrath, D., and Huse, W. D. (1996) Improving the copy numbers of antibody fragments expressed on the major coat protein of bacteriophage M13. Immunotechnology 2, 197–207.
Maynard, J. and Georgiou, G. (2000) Antibody engineering. Annu. Rev. Biomed. Eng. 2, 339–376.
Maynard, J. A., Maassen, C. B., Leppla, S. H., et al. (2002) Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 20, 597–601.
Crowe, J. E., Jr., Murphy, B. R., Chanock, R. M., Williamson, R. A., Barbas, C. F., III, and Burton, D. R. (1994) Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA 91, 1386–1390.
Samuelsson, A., Yari, F., Hinkula, J., Ersoy, O., Norrby, E., and Persson, M. A. (1996) Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cells. Eur. J. Immunol. 26, 3029–3034.
Sun, W., Xiong, J., and Shulman, M. J. (1994) Production of mouse V/human C chimeric kappa genes by homologous recombination in hybridoma cells. Analysis of vector design and recombinant gene expression. J. Immunol. 152, 695–704.
Kanda, H., Mori, K., Koga, H., et al. (1994) Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector. Hybridoma 13, 359–366.
Song, Z., Cai, Y., Song, D., et al. (1997) Primary structure and functional expression of heavy-and light-chain variable region genes of a monoclonal antibody specific for human fibrin. Hybridoma 16, 235–241.
Lu, Z., Murray, K. S., Van, C. V., LaVallie, E. R., Stahl, M. L., and McCoy, J. M. (1995) Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Biotechnology (NY) 13, 366–372.
Kurz, M., Gu, K., Al Gawari, A., and Lohse, P. A. (2001) cDNA-protein fusions: covalent protein-gene conjugates for the in vitro selection of peptides and proteins. Chembiochemistry 2, 666–672.
Kurz, M., Gu, K., and Lohse, P. A. (2000) Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions. Nucleic Acids Res. 28, E83.
Kreider, B. L. (2000) PROfusion: genetically tagged proteins for functional proteomics and beyond. Med. Res. Rev. 20, 212–215.
Tuerk, C. and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510.
Brody, E. N. and Gold, L. (2000) Aptamers as therapeutic and diagnostic agents. Rev. Mol. Biotechnol. 74, 5–13.
Ringquist, S. and Parma, D. (1998) Anti-L-selectin oligonucleotide ligands recognize CD62L-positive leukocytes: binding affinity and specificity of univalent and bivalent ligands. Cytometry 33, 394–405.
Willis, M. C., LeCuyer, K. A., Meisenheimer, K. M., Uhlenbeck, O. C., and Koch, T. H. (1994) An RNA-protein contact determined by 5-bromouridine substitution, photocrosslinking and sequencing. Nucleic Acids Res. 22, 4947–4952.
Meisenheimer, K. M., Meisenheimer, P. L., Willis, M. C., and Koch, T. H. (1996) High yield photocrosslinking of a 5-iodocytidine (IC) substituted RNA to its associated protein. Nucleic Acids Res. 24, 981, 982.
Golden, M. C., Collins, B. D., Willis, M. C., and Koch, T. H. (2000) Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. J. Biotechnol. 81, 167–178.
Eaton, B. E. and Pieken, W. A. (1995) Ribonucleosides and RNA. Annu. Rev. Biochem. 64, 837–863.
Jellinek, D., Green, L. S., Bell, C., et al. (1995) Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. BCH 34, 11,363–11,372.
Ruckman, J., Green, L. S., Beeson, J., et al. (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273, 20,556–20,567.
Yang, H., Leland, J. K., Yost, D., and Massey, R. J. (1994) Electrochemiluminescence: a new diagnostic and research tool. ECL detection technology promises scientists new “yardsticks” for quantification. Biotechnology (NY) 12, 193, 194.
Carlowicz, M. (1995) Electrochemiluminescence could spark an assay revolution. Clin. Lab. News 21, 1–3.
Kijek, T. M., Rossi, C. A., Moss, D., Parker, R. W., and Henchal, E. A. (2000) Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphylococcal enterotoxin B. J. Immunol. Methods 236, 9–17.
Higgins, J. A., Ibrahim, M. S., Knauert, F. K., et al. (1999) Sensitive and rapid identification of biological threat agents. Ann. NY Acad. Sci. 894, 130–148.
Barnard, G., Helmick, B., Madden, S., Gilbourne, C., and Patel, R. (2000) The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE. Luminescence 15, 357–362.
Crooks, S. R., Ross, P., Thompson, C. S., Haggan, S. A., and Elliott, C. T. (2000) Detection of unwanted residues of ivermectin in bovine milk by dissociation-enhanced lanthanide fluoroimmunoassay. Luminescence 15, 371–376.
Hierholzer, J. C., Johansson, K. H., Anderson, L. J., Tsou, C. J., and Halonen, P. E. (1987) Comparison of monoclonal time-resolved fluoroimmunoassay with monoclonal capturebiotinylated detector enzyme immunoassay for adenovirus antigen detection. J. Clin. Microbiol. 25, 1662–1667.
Hemmila, I., Dakubu, S., Mukkala, V. M., Siitari, H., and Lovgren, T. (1984) Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137, 335–343.
Merio, L., Pettersson, K., and Lovgren, T. (1996) Monoclonal antibody-based dual-label time-resolved fluorometric assays in a simplified one-step format. Clin. Chem. 42, 1513–1517.
Carson, R. T. and Vignali, D. A. (1999) Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 227, 41–52.
Fulton, R. J., McDade, R. L., Smith, P. L., Kienker, L. J., and Kettman, J. R., Jr. (1997) Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 43, 1749–1756.
Perrin, F. (1926) Radium. J. Phys. 7, 390–401.
Checovich, W. J., Bolger, R. E., and Burke, T. (1995) Fluorescence polarization—a new tool for cell and molecular biology. Nature (London) 375, 254–256.
Nielsen, K., Gall, D., Jolley, M., et al. (1996) A homogeneous fluorescence polarization assay for detection of antibody to Brucella abortus. J. Immunol. Methods 195, 161–168.
Urios, P. and Cittanova, N. (1990) Adaptation of fluorescence polarization immunoassay to the assay of macromolecules. Anal. Biochem. 185, 308–312.
Tencza, S. B., Islam, K. R., Kalia, V., Nasir, M. S., Jolley, M. E., and Montelaro, R. C. (2000) Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus. J. Clin. Microbiol. 38, 1854–1859.
LeTilly, V. and Royer, C. A. (1993) Fluorescence anisotropy assays implicate protein-protein interactions in regulating trp repressor DNA binding. BCH 32, 7753–7758.
Singh, K. K., Rucker, T., Hanne, A., Parwaresch, R., and Krupp, G. (2000) Fluorescence polarization for monitoring ribozyme reactions in real time. BT 29, 344–341.
Bolger, R., Lenoch, F., Allen, E., Meiklejohn, B., and Burke T. (1997) Fluorescent dye assay for detection of DNA in recombinant protein products. BT 23, 532–537.
Maeda, H. (1979) Assay of proteolytic enzymes by the fluorescence polarization technique. Anal. Biochem. 92, 222–227.
Harris, P. and Stephenson, J. (2000) Automating POC instrumentation: a systems view. IVD Technol. 6, 45–49.
Niedbala, R. S., Feindt, H., Kardos, K., et al. (2001) Detection of analytes by immunoassay using up-converting phosphor technology. Anal. Biochem. 293, 22–30.
Corstjens, P., Zuiderwijk, M., Brink, A., et al. (2001) Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin. Chem. 47, 1885–1893.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Ludwig, G.V., Rossi, C.A., Bull, R.L. (2005). Concepts for the Development of Immunodiagnostic Assays for Detection and Diagnosis of Biothreat Agents. In: Lindler, L.E., Lebeda, F.J., Korch, G.W. (eds) Biological Weapons Defense. Infectious Disease. Humana Press. https://doi.org/10.1385/1-59259-764-5:551
Download citation
DOI: https://doi.org/10.1385/1-59259-764-5:551
Publisher Name: Humana Press
Print ISBN: 978-1-58829-184-4
Online ISBN: 978-1-59259-764-2
eBook Packages: MedicineMedicine (R0)